亚太地区护理点分子诊断市场预测至 2028 年 - 按产品和服务（检测和试剂盒、仪器、服务和软件）、技术 [PCR、等温核酸扩增技术 (INAAT) 划分的 COVID-19 影响和区域分析和其他技术]、应用（传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用）和最终用户（医院和诊所、诊断实验室、研究和学术机构等）
No. of Pages: 208 | Report Code: TIPRE00026189 | Category: Life Sciences
No. of Pages: 208 | Report Code: TIPRE00026189 | Category: Life Sciences
市场的增长主要归因于对特定病毒的需求不断增长消耗较少时间的检测方法可以及时控制感染并防止传染病发病率上升。此外，亚太地区即时分子诊断不断增长的研发和创新预计将在预测期内促进市场增长。然而，报销削减带来的定价压力阻碍了市场增长。 COVID-19 大流行对即时分子诊断市场产生了重大的积极影响。在大流行期间，对快速检测 COVID-19 的诊断试剂盒的需求不断增加，推动了世界各地对即时检测的采用。 COVID-19 病例数量不断增加，以及世界各国政府改善患者管理的压力日益增大，增加了对可在护理点环境中有效使用的快速抗原检测试剂盒的需求。
基于产品和服务方面，亚太地区即时分子诊断市场分为检测和诊断服务。套件、仪器、服务和服务；软件。化验&套件细分市场领先，预计在预测期内复合年增长率最高。根据技术，亚太地区即时分子诊断市场分为PCR、等温核酸扩增技术（INAAT）和其他技术。 PCR 领域引领市场，而等温核酸扩增技术 (INAAT) 领域预计在预测期内复合年增长率最高。按应用划分，亚太地区即时分子诊断市场分为传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用。传染病领域在亚太地区即时分子诊断市场中占有最大份额。然而，预计肿瘤学领域在预测期内将实现市场上最高的复合年增长率。按最终用户划分，亚太地区即时分子诊断市场分为医院和医院。诊所、诊断实验室、研究和实验室学术机构等。诊断实验室领域引领市场，预计在预测期内复合年增长率最高。
即时护理 (POC) 分子检测准确且可扩展，扩大了疾病诊断的范围，可以在社区和实验室之外进行。与实验室检测相比，即时分子诊断具有多种优势，例如更少的就诊次数、更短的住院时间、更好的药物治疗优化以及更少的不当药物使用。由于整个行业中新技术和有效技术的出现，医疗保健行业正在经历巨大的变革。因此，对比实验室测试花费更少时间的有效诊断的需求不断增长，推动了对 POC 分子检测和试剂盒的需求，从而推动亚太地区即时分子诊断市场在预测期内的增长。< /p>
世界卫生组织 (WHO)、疾病控制与预防中心 (CDC) 和国际癌症研究机构是在准备报告时提到的一些主要和次要来源亚太地区即时分子诊断市场。
Strategic insights for Asia Pacific Point-of-Care Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 499.19 Million |
| Market Size by 2028 | US$ 1,251.67 Million |
| Global CAGR (2022 - 2028) | 14.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品与服务
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Point-of-Care Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Point-of-Care Molecular Diagnostics Market is valued at US$ 499.19 Million in 2021, it is projected to reach US$ 1,251.67 Million by 2028.
As per our report Asia Pacific Point-of-Care Molecular Diagnostics Market, the market size is valued at US$ 499.19 Million in 2021, projecting it to reach US$ 1,251.67 Million by 2028. This translates to a CAGR of approximately 14.0% during the forecast period.
The Asia Pacific Point-of-Care Molecular Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Point-of-Care Molecular Diagnostics Market report:
The Asia Pacific Point-of-Care Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Point-of-Care Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Point-of-Care Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Point-of-Care Molecular Diagnostics Market
